Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
Navarro-Jarabo JM, Fernández N, Sousa FL, Cabrera E, Castro M, Ramírez LM, Rivera R, Ubiña E, Vera F, Méndez I, Rivas-Ruiz F, Moreno JL, Perea-Milla E
BMC Gastroenterol 2007, 7:31
[Full text] [PubMed] [Related articles]
|
No citations for this article were found in PubMed Central.
|
